Safety and Efficacy of OCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Refractory Type 2 Diabetes Mellitus
Clinical trial NCT06727721 · RECRUITING
Trial details
- NCT number
- NCT06727721
- Sponsor
- Lu jin ，MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-06
- Primary completion
- 2028-12-12
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.